Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users

By Loughlin A.   Metsch L.   Gardner L.   Anderson-mahoney P.   Barrigan M.   Strathdee S.  

AIDS Care, Vol. 16, Iss. 4, 2004-05 ,pp. : 485-500

Routledge Ltd

Access to resources Recommend Favorite

Treatment and prevention of cytomegalovirus-associated diseases in HIV-1 infection in the era of HAART

By Meyer-Olson Dirk   Schmidt Reinhold E   Bollmann Benjamin A  

HIV Therapy, Vol. 4, Iss. 4, 2010-07 ,pp. : 413-436

Future Medicine

Access to resources Recommend Favorite

Surgeons' attitudes toward HIV/AIDS in Turkey

By Duyan V.   Agalar F.   Sayek I.  

AIDS Care, Vol. 13, Iss. 2, 2001-04 ,pp. : 243-250

Routledge Ltd

Access to resources Recommend Favorite

Changing attitudes towards antiretroviral treatment of HIV infection: a prospective study in a sample of Dutch general practitioners

By Reedijk M.   Bindels P. J. E.   Mohrs J.   Wigersma L.  

AIDS Care, Vol. 11, Iss. 2, 1999-04 ,pp. : 141-145

Routledge Ltd

Access to resources Recommend Favorite

Treatment of Opportunistic Infections Prior to HAART Initiation Does Not Affect Immune Reconstitution in HIV-Infected Patients

By  

Current HIV Research, Vol. 10, Iss. 7, 2012-09 ,pp. : 592-596

Bentham Science Publishers

Access to resources Recommend Favorite